Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-11

FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for atorvastatin calcium, expanding the availability of a generic statin product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

SUPPL AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)